Suppr超能文献

亚急性甲状腺炎后甲状腺低回声区的范围与甲状腺功能障碍有关。

Extent of hypoechogenic area in the thyroid is related with thyroid dysfunction after subacute thyroiditis.

作者信息

Nishihara E, Amino N, Ohye H, Ota H, Ito M, Kubota S, Fukata S, Miyauchi A

机构信息

Kuma Hospital, Center for Excellence in Thyroid Care, Kobe, Japan.

出版信息

J Endocrinol Invest. 2009 Jan;32(1):33-6. doi: 10.1007/BF03345675.

Abstract

OBJECTIVE

To gain an insight into risk factors for hypothyroidism after subacute thyroiditis (SAT), we examined the correlation between initial laboratory and ultrasonographic findings and sequential thyroid dysfunction among treatment modalities.

PATIENTS

We reviewed retrospectively the medical records of 252 patients (26 men and 226 women) with SAT who consecutively visited our thyroid clinic at Kuma Hospital for at least 6 months from 1996 through 2004.

RESULTS

Throughout the course, 135 patients (53.6%) developed transient or permanent hypothyroidism. Levels of TSH were most often elevated (greater than 5 IU/ml) 2 months after SAT onset regardless of treatment, and 97.0% of patients who showed transient or permanent hypothyroidism clustered within 6 months from onset. During follow-up, patients treated with prednisone (PSL) were more likely to have normal thyroid function than patients not treated or those receiving anti-inflammatory drug therapy. In patients who developed hypothyroidism with PSL treatment or without treatment, the rates of bilateral hypoechogenic areas (HEA) were 6-fold higher than those of unilateral HEA. Moreover, permanent hypothyroidism occurred in 5.9% of patients, and all patients with permanent hypothyroidism presented initially with bilateral HEA and had consequently small thyroid size with or without abnormal autoimmunity.

CONCLUSIONS

The rates of thyroid dysfunction after SAT were significantly lower in patients receiving PSL. Extent of HEA in the thyroid, but not laboratory findings, may be a possible marker for developing thyroid dysfunction after SAT.

摘要

目的

为深入了解亚急性甲状腺炎(SAT)后甲状腺功能减退的危险因素,我们研究了初始实验室检查及超声检查结果与不同治疗方式下甲状腺功能随时间变化之间的相关性。

患者

我们回顾性分析了1996年至2004年间连续6个月以上到熊本医院甲状腺门诊就诊的252例SAT患者(26例男性,226例女性)的病历。

结果

在整个病程中,135例患者(53.6%)出现了短暂性或永久性甲状腺功能减退。无论采用何种治疗方式,SAT发病后2个月时促甲状腺激素(TSH)水平最常升高(大于5 IU/ml),且97.0%出现短暂性或永久性甲状腺功能减退的患者在发病后6个月内出现。随访期间,接受泼尼松(PSL)治疗的患者甲状腺功能正常的可能性高于未治疗或接受抗炎药物治疗的患者。在接受PSL治疗或未治疗而出现甲状腺功能减退的患者中,双侧低回声区(HEA)的发生率比单侧HEA高6倍。此外,5.9%的患者发生了永久性甲状腺功能减退,所有永久性甲状腺功能减退患者最初均表现为双侧HEA,随后甲状腺体积缩小,伴或不伴有自身免疫异常。

结论

接受PSL治疗的SAT患者甲状腺功能障碍的发生率显著较低。甲状腺HEA的范围而非实验室检查结果可能是SAT后发生甲状腺功能障碍的一个潜在指标。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验